Clarity Pharmaceuticals Ltd (ASX: CU6)
Australia flag Australia · Delayed Price · Currency is AUD
5.97
-0.09 (-1.49%)
Nov 21, 2024, 4:10 PM AEST

Clarity Pharmaceuticals Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Nov '24 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2019 - 2018
Market Capitalization
1,9121,689182132--
Upgrade
Market Cap Growth
825.73%825.73%38.70%---
Upgrade
Enterprise Value
1,7751,65110735--
Upgrade
Last Close Price
5.975.420.700.51--
Upgrade
PS Ratio
141.72146.7918.6220.37--
Upgrade
PB Ratio
12.7211.552.641.43--
Upgrade
P/TBV Ratio
11.5511.552.641.43--
Upgrade
EV/Sales Ratio
154.27143.4910.875.40--
Upgrade
Asset Turnover
0.100.100.110.110.200.29
Upgrade
Quick Ratio
18.4418.449.9513.199.919.43
Upgrade
Current Ratio
19.0519.0510.1713.2610.009.56
Upgrade
Return on Equity (ROE)
-39.29%-39.29%-30.48%-42.23%-71.89%-80.00%
Upgrade
Return on Assets (ROA)
-24.19%-24.19%-18.65%-17.40%-40.63%-45.29%
Upgrade
Return on Capital (ROIC)
-25.99%-25.99%-20.42%-18.94%-45.33%-50.74%
Upgrade
Earnings Yield
-2.60%-2.51%-13.48%-18.06%--
Upgrade
FCF Yield
-2.29%-2.59%-15.10%-10.28%--
Upgrade
Buyback Yield / Dilution
-5.22%-5.22%-4.81%-40.37%-20.54%-2.86%
Upgrade
Total Shareholder Return
-5.22%-5.22%-4.81%-40.37%-20.54%-2.86%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.